Your email has been successfully added to our mailing list.

×
0.0274040857000499 0.0313901345291479 0.0194319880418535 0.0144494270054808 0.0214250124564026 0.0244145490782263 0.0346287992027902 0.0652715495764824
Stock impact report

Viela Bio jumps 9% in trading debut before paring gains [MarketWatch]

Viela Bio, Inc. (VIE) 
Company Research Source: MarketWatch
Viela Bio jumps 9% in trading debut before paring gains Shares of Viela Bio Inc. VIE, +5.74% rose 9% in their trading debut Thursday, before paring some of those gains, after the company sold 7.9 million shares in its initial public offering, priced at $19 each, the low end of its range. The company, a clinical-stage biotech, specializes in treatments for autoimmune and severe inflammatory diseases. Goldman Sachs, Morgan Stanley and Cowen were lead underwriters on the deal with Guggenheim acting as co-manager. The stock is trading on Nasdaq, under the ticker symbol "VIE." Proceeds of the deal will be used to fund clinical trials and for working capital and other general corporate purposes. Show less Read more
Impact Snapshot
Event Time:
VIE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for VIE alerts
Opt-in for
VIE alerts

from News Quantified
Opt-in for
VIE alerts

from News Quantified